All In Biotech

Drug Trial Radar · NCT03674008

A Phase III Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia

A Phase III,Randomized, Double-blind, Propofol-controlled, Parallel-design, Multi-center Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia in Patients Undergoing Colonoscopy and Gastroscopy

Last checked: Nov 19, 2026Latest source record: Jul 5, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 280 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

280

Actual

Start

Oct 9, 2018

Primary completion

Jan 9, 2019

Study completion Mar 10, 2019

Sponsor

Sponsor type
Industry
First posted
Sep 17, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase III, randomized, double-blind, propofol-controlled, parallel-design, multi-center study to evaluate the efficacy and safety of HSK3486 for sedation or anesthesia in patients undergoing colonoscopy and gastroscopy. The study will enroll approximately 280 adults. The maximum study duration is anticipated to be up to nine months.

Conditions

  • Sedation or Anesthesia

Interventions

  • HSK3486Drug

    HSK3486 intravenous (iv) 0.4 mg/kg for induction, and 0.2 mg/kg top-ups for maintenance.

  • PropofolDrug

    Propofol iv 1.5 mg/kg for induction, and 0.75 mg/kg top-ups for maintenance.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Success of colonoscopy procedureTime frame: from the first dose of the study drug to removal of colonoscope on day 1

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • West China Hospital, Sichuan University

    Changde, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.